Understanding how Dot1L affects bone growth and development
The role of Dot1L activity in chondrogenic differentiation
This study is looking at how a protein called Dot1L helps bones grow and develop properly, which could lead to new treatments for kids with bone growth issues.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Connecticut Sch of Med/dnt NIH-funded |
| Lab location | 1 site (Farmington, United States) |
| Project ID | NIH-10852009 on NIH RePORTER |
What this research studies
This research investigates the role of Dot1L, a chromatin modifier, in the normal growth and development of bones. By examining how Dot1L influences gene expression and cell differentiation, the study aims to fill a critical knowledge gap regarding skeletal development. The researchers will utilize various methodologies, including CRISPR technology, to explore both the catalytic and non-catalytic functions of Dot1L in chondrocytes, which are essential for cartilage and bone formation. The findings could lead to new therapeutic approaches for pediatric conditions related to bone growth.
Who could benefit from this research
Good fit: Ideal candidates for participation would be children under 11 years old who are experiencing issues with bone development or related conditions.
Not a fit: Patients with fully developed skeletal systems or those over the age of 11 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for pediatric bone growth disorders and related cancers.
How similar studies have performed: While the specific role of Dot1L in skeletal development is not extensively studied, related research on chromatin modifiers has shown promise in understanding and treating various conditions.
Where this research is happening
Farmington, United States
- University of Connecticut Sch of Med/dnt — Farmington, United States (Active)
Researchers
- Principal investigator: Guzzo, Rosaria M. — University of Connecticut Sch of Med/dnt
- Study coordinator: Guzzo, Rosaria M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.